Accell Group N.V. financials
Accell Group N.V.
Country: NL Reporting currency: EUR Latest annual report: 2021-12-31
LEI:
724500PZHSQTJODTGY09 Financial statements
(EUR, as reported — unscaled; 106 line items across 2 annual periods)
| Line item | 2021 | 2020 |
|---|---|---|
| Income statement | ||
| Revenue | €1.38B | €1.30B |
| Other income | €1.1M | €127.0K |
| Employee benefits expense | €168.9M | €148.9M |
| Raw materials & consumables used | €955.8M | €934.7M |
| Operating profit (EBIT) | €110.1M | €74.7M |
| Net finance income / (cost) | -€23.7M | -€12.8M |
| Profit before tax | €91.5M | €62.9M |
| Income tax expense | €21.5M | -€1.9M |
| Profit for the year | €70.0M | €64.8M |
| Total comprehensive income | €79.6M | €52.4M |
| Per share | ||
| Basic EPS | €2.61 | €2.42 |
| Diluted EPS | €2.60 | €2.41 |
| Free cash flow / share | €-4.90 | €7.29 |
| Cash flow statement | ||
| Cash generated from operations | -€101.9M | €227.6M |
| Net cash from operating activities | -€120.7M | €206.5M |
| Income taxes paid | €10.4M | €10.8M |
| Net cash from investing activities | -€3.4M | -€11.1M |
| Purchase of PP&E (capex) | €11.2M | €10.3M |
| Purchase of intangibles | €1.1M | €1.1M |
| Net cash from financing activities | -€27.3M | -€7.3M |
| Dividends paid | €0 | €0 |
| Proceeds from borrowings | €105.1M | €197.7M |
| Repayments of borrowings | €122.4M | €190.2M |
| Lease liability payments | €10.1M | €10.1M |
| Net change in cash | -€151.4M | €188.0M |
| Balance sheet | ||
| Total assets | €1.06B | €879.6M |
| Non-current assets | €272.9M | €289.1M |
| Property, plant & equipment | €67.0M | €66.2M |
| Right-of-use assets | €29.2M | €28.1M |
| Intangible assets & goodwill | €126.6M | €127.0M |
| Current assets | €786.7M | €590.4M |
| Inventories | €556.8M | €285.3M |
| Trade & other receivables | €160.7M | €128.5M |
| Cash & equivalents | €48.5M | €173.4M |
| Total equity | €456.1M | €376.0M |
| Non-current liabilities | €175.8M | €235.5M |
| Long-term borrowings | €126.2M | €184.7M |
| Lease liabilities (non-current) | €20.5M | €20.2M |
| Current liabilities | €427.8M | €268.1M |
| Short-term borrowings | €60.7M | €19.8M |
| Lease liabilities (current) | €9.7M | €8.8M |
| Trade & other payables | €276.6M | €186.9M |
| Deferred tax liabilities | €14.2M | €15.9M |
| Derived metrics | ||
| Free cash flow | -€131.9M | €196.1M |
| Operating margin | 8.0% | 5.8% |
| Net margin | 5.1% | 5.0% |
| Return on equity | 15.3% | 17.2% |
| Cash conversion ratio | -1.72× | 3.18× |
| Capex coverage | -10.79× | 19.97× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | -€299.7M | €103.0M |
| Adjustments For Decrease Increase In Trade and Other Receivables | -€35.7M | €39.7M |
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €20.9M | €24.9M |
| Adjustments For Finance Income Cost | -€23.7M | -€12.8M |
| Adjustments For Gain Loss On Disposal of Investments In Subsidiaries Joint Ventures and Associates | €2.4M | €0 |
| Adjustments For Gain Loss On Disposals Property Plant and Equipment | €18.0K | €10.0K |
| Adjustments For Income Tax Expense | €21.5M | -€1.9M |
| Adjustments For Increase Decrease In Trade and Other Payables | €96.1M | -€20.8M |
| Adjustments For Sharebased Payments | €619.0K | €351.0K |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | €2.7M | €1.0M |
| Bank Overdrafts Classified As Cash Equivalents | €48.3M | €19.0M |
| Cash and Cash Equivalents If Different From Statement of Financial Position | €203.0K | €154.3M |
| Cash Flows From Losing Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €3.3M | €0 |
| Cash Flows From Used In Operations Before Changes In Working Capital | €131.6M | €100.0M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €0 | €0 |
| Current Derivative Financial Assets | €18.1M | €164.0K |
| Current Derivative Financial Liabilities | €2.9M | €15.8M |
| Current Provisions | €7.0M | €10.8M |
| Current Tax Assets Current | €2.7M | €3.1M |
| Current Tax Liabilities Current | €11.3M | €4.6M |
| Deferred Income Classified As Current | €11.3M | €2.2M |
| Deferred Income Classified As Noncurrent | €2.2M | €1.5M |
| Deferred Tax Assets | €31.2M | €38.5M |
| Depreciation Amortisation and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €21.0M | €24.9M |
| Dividends Received From Investments Accounted For Using Equity Method Classified As Investing Activities | €886.0K | €0 |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€2.7M | -€579.0K |
| Equity and Liabilities | €1.06B | €879.6M |
| Gains Losses On Cash Flow Hedges Before Tax | €20.0M | -€10.0M |
| Gains Losses On Disposals of Investments | €2.4M | €0 |
| Impairment Loss Impairment Gain and Reversal of Impairment Loss Determined In Accordance With IFRS9 | €224.0K | -€1.3M |
| Income Tax Relating To Components of Other Comprehensive Income That Will Be Reclassified To Profit Or Loss | €5.1M | -€2.4M |
| Income Tax Relating To Components of Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss | -€4.8M | -€175.0K |
| Increase Decrease Through Sharebased Payment Transactions | €619.0K | €351.0K |
| Increase Decrease Through Transactions With Owners | €619.0K | €359.0K |
| Increase Decrease Through Transfers and Other Changes Equity | €0 | €8.0K |
| Interest Paid Classified As Operating Activities | €16.8M | €18.7M |
| Interest Received Classified As Operating Activities | €8.4M | €8.3M |
| Investment Accounted For Using Equity Method | €8.3M | €6.4M |
| Issued Capital | €268.0K | €268.0K |
| Liabilities | €603.5M | €503.6M |
| Noncurrent Provisions | €4.6M | €4.5M |
| Noncurrent Provisions For Employee Benefits | €8.1M | €8.7M |
| Noncurrent Recognised Assets Defined Benefit Plan | €8.8M | €21.1M |
| Other Comprehensive Income | €9.6M | -€12.4M |
| Other Comprehensive Income Before Tax Exchange Differences On Translation | €2.9M | -€3.4M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | -€13.4M | -€841.0K |
| Other Expense By Nature | €122.3M | €114.5M |
| Other Noncurrent Financial Assets | €1.8M | €2.0M |
| Payments For Debt Issue Costs | €7.0K | €1.8M |
| Payments For Development Project Expenditure | €170.0K | €226.0K |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €1.5M | €76.0K |
| Proceeds From Sales Or Maturity of Financial Instruments Classified As Investing Activities | €3.7M | €876.0K |
| Purchase of Financial Instruments Classified As Investing Activities | €307.0K | €413.0K |
| Reclassification Adjustments On Cash Flow Hedges Before Tax | -€514.0K | -€547.0K |
| Reclassification Adjustments On Exchange Differences On Translation Before Tax | €0 | €1.3M |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €2.7M | €1.0M |
| Share Premium | €42.2M | €42.3M |
Methodology
Every line item above is a fact tagged in Accell Group N.V.'s annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.